Chiltern closes its Theorem buy, doubling its workforce

U.K. CRO Chiltern has wrapped up its acquisition of former U.S. competitor Theorem Clinical Research, expanding its payroll and global reach in the process. Without disclosing financial terms, Chiltern said the integration gives it 3,700 employees in 47 countries, bringing in new clinical trial technologies the company believes will help it grow its client base. Release

Suggested Articles

The platform uses wearables to continuously collect clinical data from study participants and applies machine learning to analyze the data.

Analytica Laser has a novel system which the company touts as the industry's first dynamic tool to predict real-world health outcomes.

Genae's CEO says the transaction reflects recent focus on digital health and data-driven services.